Barclays Maintains Overweight on Bruker, Raises Price Target to $53
Bruker Corporation
Bruker Corporation BRKR | 0.00 |
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:
BRKR) with a Overweight and raises the price target from $45 to $53.
Barclays Maintains Overweight on Bruker, Raises Price Target to $53
Bruker Corporation BRKR | 0.00 |